GENFLOW BIOSCIENCES PLC
Developing gene therapies to target the aging process in humans and dogs.
GENF | IL
Overview
Corporate Details
- ISIN(s):
- GB00BP2C3V08
- LEI:
- 213800HVOFXRXVEGDN62
- Country:
- United Kingdom
- Address:
- 6 HEDDON STREET, W1B 4BT LONDON
- Website:
- https://genflowbio.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Genflow Biosciences PLC, founded in 2020, is a biotechnology company developing gene therapies to target the aging process in both humans and dogs. The company focuses on longevity science, aiming to extend healthspan and delay the onset of age-related diseases. Its lead compound, GF-1002, is a therapy based on delivering a centenarian variant of the SIRT6 gene, which has demonstrated promising preclinical results. Genflow's research and development pipeline also includes programs targeting specific age-related conditions such as sarcopenia (muscle loss).
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for GENFLOW BIOSCIENCES PLC and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-15 08:00 |
Regulatory News Service
Genflow Signs CDAs with Animal Health Companies
|
English | 17.6 KB | |
| 2025-08-27 16:07 |
Major Shareholding Notification
Holding(s) in Company
|
English | 21.7 KB | |
| 2025-08-18 08:00 |
Regulatory News Service
Company Update on Dog Trials
|
English | 19.7 KB | |
| 2025-07-24 08:00 |
Earnings Release
Clinical Readiness Acceleration
|
English | 17.7 KB | |
| 2025-07-17 08:00 |
Capital/Financing Update
Genflow Confirms Progression of Grant
|
English | 18.0 KB | |
| 2025-06-12 11:16 |
Post-Annual General Meeting Information
Result of AGM
|
English | 30.5 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
Genflow Signs Master Services Agreement
|
English | 13.4 KB | |
| 2025-05-15 08:00 |
Regulatory News Service
Key SIRT6 Patent Application
|
English | 12.3 KB | |
| 2025-05-12 11:50 |
Major Shareholding Notification
Holding(s) in Company
|
English | 68.7 KB | |
| 2025-05-07 19:07 |
Annual Report (ESEF)
Annual financial statements 2024
|
English | 493.4 KB | |
| 2025-05-07 19:07 |
Annual Report
Annual financial statements 2024
|
English | 1.5 MB | |
| 2025-03-28 08:10 |
Major Shareholding Notification
Holding in Company
|
English | 23.0 KB | |
| 2025-03-28 08:00 |
Director's Dealing
Director Dealings
|
English | 25.2 KB | |
| 2025-03-26 08:00 |
Share Issue/Capital Change
Institutional Investment
|
English | 19.6 KB | |
| 2025-02-20 08:00 |
Regulatory News Service
Advancements in SIRT6 Variant Patent Application
|
English | 19.4 KB |
Automate Your Workflow. Get a real-time feed of all GENFLOW BIOSCIENCES PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for GENFLOW BIOSCIENCES PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
